chlorpromazine has been researched along with lorazepam in 43 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (18.60) | 18.7374 |
| 1990's | 9 (20.93) | 18.2507 |
| 2000's | 17 (39.53) | 29.6817 |
| 2010's | 7 (16.28) | 24.3611 |
| 2020's | 2 (4.65) | 2.80 |
| Authors | Studies |
|---|---|
| Andrews, PR; Craik, DJ; Martin, JL | 1 |
| Strassburg, CP; Tukey, RH | 1 |
| Duffy, EM; Jorgensen, WL | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 2 |
| Abraham, MH; Acree, WE; Ibrahim, A | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Sun, Y; Yan, Z | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Boissier, JR; Simon, P; Soubrie, P | 1 |
| Bourgeois, M; Daubech, JF; Deliac, P; Paty, J; Tignol, J | 1 |
| Schenker, S | 1 |
| Finance, F; Rohmer, F; Ruh-Bernhardt, D; Singer, L | 1 |
| Finance, MF; Ruh, MD; Singer, L | 1 |
| Dolan, JD; Kamil, R | 1 |
| Bilik, M; Danion, JM; Grangé, D; Imbs, JL; Peretti, S; Singer, L | 1 |
| Kerr, S; Marshall, G; O'Gorman-Hughes, D; Vowels, M; White, L | 1 |
| De Bonnel, G; De Montigny, C | 1 |
| Gross, EJ; Hill, JA; Hull, HG; Lytton, GJ; Piersel, WC | 1 |
| Baker, D; Fairclough, D; Mulhern, RK; Pui, CH; Relling, MV | 1 |
| Griffiths, RR; Lamb, RJ | 1 |
| Breitbart, W; Corbera, K; Derevenco, M; Grau, C; Jacobson, P; Lund, S; Marotta, R; Platt, MM; Raymond, S; Weisman, H | 1 |
| Finnerty, M; Levin, Z; Miller, LJ | 1 |
| Green, JF; King, DJ; McElholm, A | 1 |
| Green, JF; King, DJ | 1 |
| Lacroix, Y; Moghrabi, A; Pelletier, G; Robaey, P | 1 |
| Bell, R; Campbell, C; Green, JF; King, DJ; McCartan, D; Pickering, A; Trimble, K | 1 |
| Hatch, CD; Lund, BC; Perry, PJ | 1 |
| Jackson, KC; Lipman, AG | 1 |
| Boohene, J; Bruera, E; Calderon, B; Curry Iii, E; Elsayem, A; Hung, F; Munsell, MF | 1 |
| Athey, R; Forlano, R; Singh, D | 1 |
| Siman, E; Stewart, SL; Swart, GT | 1 |
| Kashyap, GL; Patel, AG | 1 |
| Candy, B; Jackson, KC; Jones, L; King, M; Leurent, B; Tookman, A | 1 |
| Harvey, R; Kekulawala, S; Kent, M; Mostafa, S; Tucker, MG | 1 |
| Candy, B; Finucane, AM; Jones, L; Leurent, B; Sampson, EL; Stone, P; Tookman, A | 1 |
| Butala, N; Kang, C; Williams, A | 1 |
5 review(s) available for chlorpromazine and lorazepam
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Drug therapy for delirium in terminally ill patients.
Topics: Antipsychotic Agents; Chlorpromazine; Delirium; Haloperidol; Humans; Lorazepam; Terminally Ill | 2004 |
Drug therapy for delirium in terminally ill adult patients.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Delirium; Haloperidol; Humans; Lorazepam; Randomized Controlled Trials as Topic; Terminally Ill | 2012 |
Drug therapy for delirium in terminally ill adults.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Delirium; Haloperidol; Humans; Lorazepam; Randomized Controlled Trials as Topic; Terminally Ill | 2020 |
7 trial(s) available for chlorpromazine and lorazepam
| Article | Year |
|---|---|
Effects of chlorpromazine and lorazepam on explicit memory, repetition priming and cognitive skill learning in healthy volunteers.
Topics: Adult; Chlorpromazine; Cognition; Double-Blind Method; Female; Humans; Learning; Lorazepam; Male; Memory; Problem Solving; Psychomotor Performance | 1992 |
Antiemetic therapy for chemotherapy-induced vomiting: metoclopramide, benztropine, dexamethasone, and lorazepam regimen compared with chlorpromazine alone.
Topics: Adolescent; Antineoplastic Agents; Benztropine; Child; Child, Preschool; Chlorpromazine; Clinical Trials as Topic; Dexamethasone; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lorazepam; Male; Metoclopramide; Random Allocation; Sleep Stages; Tropanes; Vomiting | 1989 |
Chlorpromazine with and without lorazepam as antiemetic therapy in children receiving uniform chemotherapy.
Topics: Adolescent; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Chlorpromazine; Cytarabine; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Infant; Lorazepam; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Teniposide; Vomiting | 1993 |
A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients.
Topics: Adult; AIDS Dementia Complex; Basal Ganglia Diseases; Chlorpromazine; Delirium; Double-Blind Method; Drug Administration Schedule; Female; Haloperidol; Hospitalization; Humans; Lorazepam; Male; Middle Aged; Prevalence; Psychiatric Status Rating Scales; Severity of Illness Index; Treatment Outcome | 1996 |
The effects of chlorpromazine and lorazepam on abnormal antisaccade and no-saccade distractibility.
Topics: Adult; Anti-Anxiety Agents; Antipsychotic Agents; Attention; Chlorpromazine; Frontal Lobe; Humans; Lorazepam; Male; Saccades | 1998 |
Double-blind crossover study of chlorpromazine and lorazepam in the treatment of behavioral problems during treatment of children with acute lymphoblastic leukaemia receiving glucocorticoids.
Topics: Anti-Anxiety Agents; Antipsychotic Agents; Child; Child Behavior; Child Behavior Disorders; Chlorpromazine; Cross-Over Studies; Double-Blind Method; Follow-Up Studies; Glucocorticoids; Humans; Lorazepam; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2000 |
The differential effects of chlorpromazine and haloperidol on latent inhibition in healthy volunteers.
Topics: Acoustic Stimulation; Adolescent; Adult; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Attention; Chlorpromazine; Cognition; Double-Blind Method; Haloperidol; Humans; Learning; Lorazepam; Male; Neuropsychological Tests; Paroxetine; Psychomotor Performance; Space Perception | 2001 |
31 other study(ies) available for chlorpromazine and lorazepam
| Article | Year |
|---|---|
Functional group contributions to drug-receptor interactions.
Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship | 1984 |
Prediction of drug solubility from Monte Carlo simulations.
Topics: Monte Carlo Method; Pharmaceutical Preparations; Solubility | 2000 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
Topics: Air; Animals; Humans; Lung; Organic Chemicals; Probability; Rats; Tissue Distribution; Volatilization | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
First-principle, structure-based prediction of hepatic metabolic clearance values in human.
Topics: Computational Biology; Drug Discovery; Hepatocytes; Humans; Hydrogen-Ion Concentration; Liver; Metabolic Clearance Rate; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship; Sensitivity and Specificity; Software | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
An amnesic effect of benzodiazepines in rats?
Topics: Amnesia; Animals; Anti-Anxiety Agents; Avoidance Learning; Chlordiazepoxide; Chlorpromazine; Diazepam; Humans; Lorazepam; Male; Rats | 1976 |
[Contingent negative variation and psychopharmacology].
Topics: Anti-Anxiety Agents; Chlorpromazine; Contingent Negative Variation; Electroencephalography; Electrophysiology; Evoked Potentials; Humans; Lorazepam; Morphine; Placebos | 1978 |
Effects of liver disease and of aging on the disposition and elimination of sedatives.
Topics: Aging; Anti-Anxiety Agents; Chlordiazepoxide; Chlorpromazine; Diazepam; Half-Life; Hepatitis, Viral, Human; Humans; Liver Cirrhosis; Liver Diseases; Lorazepam; Meprobamate; Oxazepam | 1978 |
[Influence of psychotropic therapy on thrombogenesis and platelet functions. A propos of 4 cases of thromboembolic accidents occurring in patients treated by neuroleptics and antidepressants].
Topics: Aged; Antidepressive Agents; Chlorpromazine; Clomipramine; Female; Humans; Lorazepam; Middle Aged; Platelet Aggregation; Pulmonary Embolism; Thromboembolism; Thrombophlebitis; Tranquilizing Agents | 1976 |
[Pulmonary embolisms occurring in 1 month in 3 aged women with manic-depressive psychoses. Discussion. Etiopathogenic role or psychiatric treatment].
Topics: Aged; Antidepressive Agents; Bipolar Disorder; Chlorpromazine; Clomipramine; Depressive Disorder, Major; Dibenzazepines; Female; Humans; Leg; Lorazepam; Middle Aged; Pulmonary Embolism; Thrombophlebitis | 1975 |
Atypical affective disorder with episodic dyscontrol: a case of von Economo's disease (encephalitis lethargica).
Topics: Adult; Antipsychotic Agents; Carbamazepine; Chlorpromazine; Chronic Disease; Electroencephalography; Encephalitis, Arbovirus; Follow-Up Studies; Humans; Lorazepam; Male; Mood Disorders; Sexual Behavior | 1992 |
Benzodiazepine selectively antagonize kainate-induced activation in the rat hippocampus.
Topics: Acetylcholine; Animals; Anti-Anxiety Agents; Benzodiazepinones; Chlorpromazine; Diazepam; Flumazenil; Glutamates; Hippocampus; Injections, Intravenous; Iontophoresis; Kainic Acid; Lorazepam; Male; Phenobarbital; Pyramidal Tracts; Pyrrolidines; Rats; Rats, Inbred Strains | 1983 |
Case study of neuroleptic-induced akathisia: important implications for individuals with mental retardation.
Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Chlorpromazine; Clorazepate Dipotassium; Diagnosis, Differential; Female; Humans; Intellectual Disability; Lorazepam; Prevalence | 1993 |
Behavioral effects of pentobarbital, lorazepam, ethanol and chlorpromazine substitution in pentobarbital-dependent baboons.
Topics: Animals; Behavior, Animal; Chlorpromazine; Ethanol; Lorazepam; Male; Papio; Pentobarbital; Substance Withdrawal Syndrome; Substance-Related Disorders | 1993 |
Acute manic episodes in pregnancy.
Topics: Adult; Bipolar Disorder; Chlorpromazine; Comorbidity; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Electroconvulsive Therapy; Female; Haloperidol; Humans; Lorazepam; Pregnancy; Pregnancy Complications; Valproic Acid | 1996 |
A comparison of the sedative and amnestic effects of chlorpromazine and lorazepam.
Topics: Adult; Chlorpromazine; Humans; Lorazepam; Male; Memory; Mental Processes; Saccades | 1996 |
Failed challenge with quetiapine after neuroleptic malignant syndrome with conventional antipsychotics.
Topics: Alzheimer Disease; Antipsychotic Agents; Chlorpromazine; Dibenzothiazepines; Haloperidol; Humans; Hyperthyroidism; Lorazepam; Male; Middle Aged; Neuroleptic Malignant Syndrome; Psychomotor Agitation; Quetiapine Fumarate | 2001 |
Use of palliative sedation for intractable symptoms in the palliative care unit of a comprehensive cancer center.
Topics: Adult; Aged; Aged, 80 and over; Cancer Care Facilities; Chlorpromazine; Female; Humans; Hypnotics and Sedatives; Lorazepam; Male; Midazolam; Middle Aged; Neoplasms; Palliative Care; Practice Patterns, Physicians'; Retrospective Studies; Young Adult | 2009 |
Neuroleptic malignant syndrome and catatonia in a patient with dementia.
Topics: Aged; Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Catatonia; Chlorpromazine; Cholinesterase Inhibitors; Cognition Disorders; Creatine Kinase; Dementia; Disease Progression; Donepezil; Female; Humans; Indans; Lorazepam; Muscle Rigidity; Neuroleptic Malignant Syndrome; Olanzapine; Piperidines; Recurrence; Risperidone | 2008 |
The use of Pro Re Nata or Statim medications for behavioral control: a summary of experience at a tertiary care children's mental health center.
Topics: Adolescent; Age Factors; Aggression; Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Child; Chlorpromazine; Diagnosis, Dual (Psychiatry); Drug Administration Schedule; Female; Humans; Intellectual Disability; Length of Stay; Lorazepam; Male; Mental Disorders; Mental Health Services; Olanzapine; Practice Patterns, Physicians'; Prospective Studies; Sex Factors | 2011 |
Unusual presentation of a patient with GBL withdrawal: a case report.
Topics: 4-Butyrolactone; Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Chlorpromazine; Delirium; Hallucinations; Haloperidol; Humans; Hypnotics and Sedatives; Illicit Drugs; Lorazepam; Male; Substance Withdrawal Syndrome | 2011 |
Polysubstance-induced relapse of schizoaffective disorder refractory to high-dose antipsychotic medications: a case report.
Topics: Adult; Amphetamine-Related Disorders; Antipsychotic Agents; Chlorpromazine; Clopenthixol; Droperidol; Drug Administration Schedule; Emergency Medical Services; Humans; Hypnotics and Sedatives; Lorazepam; Male; Marijuana Abuse; Methamphetamine; Psychotic Disorders; Time Factors; Treatment Outcome; Violence | 2016 |
Prescribing Practices for Agitation Medication in Obese Patients Admitted to the Emergency Department.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Chlorpromazine; Emergency Service, Hospital; Humans; Lorazepam; Obesity; Retrospective Studies | 2023 |